StockData

RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)

Close on Nov 17, 2026Market cap $200.90MP/E –Yield –

RxSight market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

RxSight's market cap was $219.57M on Nov 11, 2026, against $469.15M a year earlier. Over the last 5 years it ranged from $199.47M to $2.24B, with a median of $428.07M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$219.57M-48.7%
2025Dec 31, 2025$428.07M-69.1%
2024Dec 31, 2024$1.38B-4.3%
2023Dec 29, 2023$1.45B+311.6%
2022Dec 30, 2022$351.20M+14.3%
2021Dec 31, 2021$307.40M–

More RxSight figures

See a number that looks wrong?